Histone H3 K36 methylation is mediated by a trans-histone methylation pathway involving an interaction between Set2 and histone H4.
D000963:Antimetabolites / Q000494:pharmacology; D015153:Blotting, Western; D002843:Chromatin / Q000378:metabolism; D047369:Chromatin Immunoprecipitation; D015966:Gene Expression Regulation, Fungal; D006657:Histones / Q000235:genetics* / Q000378:metabolism*; D015151:Immunoblotting; D047468:Immunoprecipitation; D008239:Lysine / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D008745:Methylation; D008780:Methyltransferases / Q000235:genetics / Q000378:metabolism*; D009154:Mutation / Q000235:genetics; D009707:Nucleosomes / Q000378:metabolism; D010766:Phosphorylation; D011494:Protein Kinases / Q000378:metabolism; D011499:Protein Processing, Post-Translational; D012319:RNA Polymerase II / Q000235:genetics / Q000378:metabolism; D029701:Saccharomyces cerevisiae Proteins / Q000235:genetics / Q000378:metabolism*; D014158:Transcription, Genetic; D014498:Uracil / Q000031:analogs & derivatives / Q000494:pharmacology
D000963:Antimetabolites; C118305:CTDK-I protein complex, S cerevisiae; D002843:Chromatin; D006657:Histones; D009707:Nucleosomes; D029701:Saccharomyces cerevisiae Proteins; D014498:Uracil; D008780:Methyltransferases; C448996:Set2 protein, S cerevisiae; D011494:Protein Kinases; D012319:RNA Polymerase II; C100248:azauracil; D008239:Lysine